Type 2 diabetes mellitus: Not quite exciting enough?

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  Ashcroft, Frances ^a   Rorsman, Patrik ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG TARGETING; ELECTRIC ACTIVITY; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHESIS; IN VITRO STUDY; INFORMATION PROCESSING; INSULIN RELEASE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PREDICTION; PRIORITY JOURNAL; REVIEW; WESTERN HEMISPHERE;

AGE FACTORS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ELECTROPHYSIOLOGY; GLUCOSE INTOLERANCE; HUMANS; INSULIN; ION CHANNELS; ISLETS OF LANGERHANS; POLYMORPHISM, GENETIC;

EID: 1842579441     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Ashcroft, F.M. and Ashcroft, S.J.H. (1992) Insulin - Molecular Biology to Pathology. Oxford University Press, Oxford.
2. Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-787.
3. World Health Organization (1985) Diabetes Mellitus: A Report of a World Study Group. WHO, Geneva.
4. King, H., Aubert, R.E. and Herman, W.H. (1998) Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431.
5. Rosenbloom, A.L., Joe, J.R., Young, R.S. and Winter, W.E. (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22, 345-354.
6. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
7. Bell, G.I. and Polonsky, K.S. (2001) Diabetes mellitus and genetically programmed defects in β-cell function. Nature, 414, 788-791.
8. Kahn, S.E. (2003) The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia, 46, 3-19.
9. Jensen, C.C., Cnop, M., Hull, R.L., Fujimoto, W.Y. and Kahn, S.E. (2002) β-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes, 51, 2170-2178.
10. Bell, G.I., Pilkis, S.J., Weber, I.T. and Polonsky, K.S. (1996) Glucokinase mutations, insulin secretion, and diabetes mellitus. A. Rev. Physiol., 58, 171-186.
11. UKPDS Group (1995) UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes, 44, 1249-1258.
12. UKPDS Group (1988) UK Prospective Diabetes Study. V. Characteristics of newly presenting type 2 diabetic patients: Estimated insulin sensitivity and islet 4-cell function. Multi-centre study. Diabet. Med., 5, 444-448.
13. Pimenta, W., Korytkowski, M., Mitrakou, A., Jenssen, T., Yki-Jarvinen, H., Evron, W., Dailey, G. and Gerich, J. (1995) Pancreatic β-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA, 273, 1855-1861.
14. van Haeften, T.W., Dubbeldam, S., Zonderland, M.L. and Erkelens, D.W. (1998) Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care, 21, 278-282.
15. Gerich, J.E. (1998) The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev., 19, 491-503.
16. Taylor, S.I. (1992) Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes, 41, 1473-1490.
17. Chalkley, S.M., Hettiarachchi, M., Chisholm, D.J. and Kraegen, E.W. (2002) Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am. J. Physiol. Endocrinol. Metab., 282, E1231-1238.
18. Gerich, J.E. (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes, 51, S117-S121.
19. Rahier, J., Goebbels, R.M. and Henquin, J.C. (1983) Cellular composition of the human diabetic pancreas. Diabetologia, 24, 366-371.
20. Stefan, Y., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y. and Unger, R.H. (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes, 31, 694-700.
21. Clark, A., Jones, L.C., de Koning, E., Hansen, B.C. and Matthews, D.R. (2001) Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function? Diabetes, 50, S169-S171.
22. Porte, D. Jr and Kahn, S.E. (2001) β-cell dysfunction and failure in type 2 diabetes: Potential mechanisms. Diabetes, 50, S160-S163.
23. Clark, A., Wells, C.A., Buley, I.D., Cruickshank, J.K., Vanhegan, R.I., Matthews, D.R., Cooper, G.J., Holman, R.R. and Turner, R.C. (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes. Diabetes Res., 9, 151-159.
24. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler, P.C. (2003) β-cell deficit and increased β -cell apoptosis in humans with type 2 diabetes. Diabetes, 52, 102-110.
25. McCulloch, D.K., Koerker, D.J., Kahn, S.E., Bonner-Weir, S. and Palmer, J.P. (1991) Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes, 40, 673-679.
26. Foulis, A.K. and Stewart, J.A. (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: Insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia, 26, 456-461.
27. Ashcroft, F.M. and Rorsman, P. (1989) Electrophysiology of the pancreatic β-cell. Prog. Biophys. Mol. Biol., 54, 87-143.
28. Henquin, J.C. and Meissner, H.P. (1984) Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells. Experientia, 40, 1043-1052.
29. Henquin, J.C. (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes, 49, 1751-1760.
30. Rorsman, P. and Renstrom, E. (2003) Insulin granule dynamics in pancreatic β cells. Diabetologia, 46, 1029-1045.
31. Ashcroft, F.M., Harrison, D.E. and Ashcroft, S.J. (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature, 312, 446-448.
32. + channels and insulin secretion: Their role in health and disease. Diabetologia, 42, 903-919.
33. Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W., Clement, J.P.t., Boyd, A.E. III, Gonzalez, G., Herrera-Sosa, H., Nguy, K., Bryan, J. and Nelson, D.A. (1995) Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science, 268, 423-426.
34. Henquin, J.C. (1992) The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work? Diabetologia, 35, 907-912.
35. + channel in mouse pancreatic β-cells. Pflugers Arch., 407, 493-499.
36. Sanchez-Andres, J.V., Gomis, A. and Valdeolmillos, M. (1995) The electrical activity of mouse pancreatic β-cells recorded in vivo shows glucose-dependent oscillations. J. Physiol., 486, 223-228.
37. ATP-channel modulation. J. Physiol., 545, 501-507.
38. Meissner, H.P. (1976) Electrophysiological evidence for coupling between β cells of pancreatic islets. Nature, 262, 502-504.
39. Eddlestone, G.T., Goncalves, A., Bangham, J.A. and Rojas, E. (1984) Electrical coupling between cells in islets of Langerhans from mouse. J. Membr. Biol., 77, 1-14.
40. i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch., 418, 417-422.
41. 2+ in pancreatic islets correspond to pulsatile insulin release. Am. J. Physiol., 268, E282-E287.
42. ATP channel-independent regulation of insulin secretion. J. Biol. Chem., 275, 9270-9277.
43. + channels in mouse B cells. J. Clin. Invest., 89, 1288-1295.
44. Porksen, N., Hollingdal, M., Juhl, C., Butler, P., Veldhuis, J.D. and Schmitz, O. (2002) Pulsatile insulin secretion: Detection, regulation, and role in diabetes. Diabetes, 51, S245-S254.
45. Ward, W.K., Bolgiano, D.C., McKnight, B., Halter, J.B. and Porte, D. Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest., 74, 1318-1328.
46. Fritsche, A., Stefan, N., Hardt, E., Haring, H. and Stumvoll, M. (2000) Characterisation of β-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion. Diabetologia, 43, 852-858.
47. Kjems, L.L., Holst, J.J., Volund, A. and Madsbad, S. (2003) The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes, 52, 380-386.
48. Stumvoll, M., Fritsche, A. and Haring, H.U. (2002) Clinical characterization of insulin secretion as the basis for genetic analyses. Diabetes, 51, S122-S129.
49. Kindmark, H., Kohler, M., Arkhammar, P., Efendic, S., Larsson, O., Linder, S., Nilsson, T. and Berggren, P.O. (1994) Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance. Diabetologia, 37, 1121-1131.
50. Fernandez-Alvarez, J., Conget, I., Rasschaert, J., Sener, A., Gomis, R. and Malaisse, W.J. (1994) Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 37, 177-181.
51. Sakura, H., Wat, N., Horton, V., Millns, H., Turner, R.C. and Ashcroft, F.M. (1996) Sequence variations in the human Kir6.2 gene, a subunit of the β-cell ATP-sensitive K-channel: No association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia, 39, 1233-1236.
52. + channel Kir6.2 (Bir) gene: Identification and lack of role in Caucasian patients with NIDDM. Diabetes, 46, 502-507.
53. + channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia, 41, 1511-1515.
54. + channels. Diabetes, 51, 875-879.
55. Schwanstecher, C., Neugebauer, B., Schulz, M. and Schwanstecher, M. (2002) The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic β-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes, 51, S363-S367.
56. Nielsen, E.M., Hansen, L., Carstensen, B., Echwald, S.M., Drivsholm, T., Glumer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T. and Pedersen, O. (2003) The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes, 52, 573-577.
57. Love-Gregory, L., Wasson, J., Lin, J., Skolnick, G., Suarez, B. and Permutt, M.A. (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARγ Pro12Ala variant. Diabetologia, 46, 136-137.
58. ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes, 52, 568-572.
59. Barroso, I., Luan, J., Middelberg, R.P., Harding, A.H., Franks, P.W., Jakes, R.W., Clayton, D., Schafer, A.J., O'Rahilly, S. and Wareham, N.J. (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol., 1, 41-55.
60. Schwanstecher, C. and Schwanstecher, M. (2002) Nucleotide sensitivity of pancreatic ATP-sensifive potassium channels and type 2 diabetes. Diabetes, 51, S358-S362.
61. ATP channels induces profound neonatal diabetes. Cell, 100, 645-654.
62. + channel in the β-cell. Diabetes, 51, 3135-3138.
63. Tschritter, O., Stumvoll, M., Machicao, F., Holzwarth, M., Weisser, M., Maerker, E., Teigeler, A., Haring, H. and Fritsche, A. (2002) The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes, 51, 2854-2860.
64. + channel overexpression in transgenic islets and β-cells associated with impaired glucose responsiveness. J. Biol. Chem., 269, 27787-27790.
65. 2+ channel null mice. EMBO J., 22, 3844-3854.
66. 2+ currents in mouse pancreatic B-cells towards negative potentials. Pflugers Arch., 441, 587-595.
67. Larsson-Nyren, G. (1996) Perchlorate is hypoglycaemic by amplifying glucose-stimulated insulin secretion in mice. Acta Physiol. Scand., 158, 71-76.
68. 2+ channels by glucose metabolism in mouse pancreatic β-cells. Nature, 342, 550-553.
69. Sellick, G.S., Garrett, C. and Houlston, R.S. (2003) A novel gene for neonatal diabetes maps to chromosome 10p12.1-p13. Diabetes, 52, 2636-2638.
70. Kanno, T., Gopel, S.O., Rorsman, P. and Wakui, M. (2002) Cellular function in multicellular system for hormone-secretion: electrophysiological aspect of studies on α- β- and δ -cells of the pancreatic islet. Neurosci. Res., 42, 79-90.
71. + channels contributes to rhythmic firing of action potentials in mouse pancreatic β cells. J. Gen. Physiol., 114, 759-770.
72. 2+: experimental and theoretical studies. J. Gen. Physiol., 120, 307-322.
73. Shyng, S.L. and Nichols, C.G. (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science, 282, 1138-1141.
74. Gloyn, A.L. (2003) Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum. Mutat., 22, 353-362.
75. Yamagata, K., Oda, N., Kaisaki, P.J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R.D., Lathrop, G.M., Boriraj, V.V. et al. (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature, 384, 455-458.
76. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P.J., Menzel, S., Cox, N.J., Fajans, S.S., Signorini, S., Stoffel, M. and Bell, G.I. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature, 384, 458-460.
77. Fajans, S.S., Bell, G.I. and Polonsky, K.S. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New. Engl. J. Med., 345, 971-980.
78. Frayling, T.M., Evans, J.C., Bulman, M.P., Pearson, E., Allen, L., Owen, K., Bingham, C., Hannemann, M., Shepherd, M., Ellard, S. et al. (2001) β-cell genes and diabetes: Molecular and clinical characterization of mutations in transcription factors. Diabetes, 50, S94-S100.
79. Wang, H., Hagenfeldt-Johansson, K., Otten, L.A., Gauthier, B.R., Herrera, P.L. and Wollheim, C.B. (2002) Experimental models of transcription factor-associated maturity-onset diabetes of the young. Diabetes, 51, S333-S342.
80. Shih, D.Q., Screenan, S., Munoz, K.N., Philipson, L., Pontoglio, M., Yaniv, M., Polonsky, K.S. and Stoffel, M. (2001) Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes, 50, 2472-2480.
81. Sakura, H., Ashcroft, S.J., Terauchi, Y., Kadowaki, T. and Ashcroft, F.M. (1998) Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice. Diabetologia, 41, 654-659.
82. Dukes, I.D., Sreenan, S., Roe, M.W., Levisetti, M., Zhou, Y.P., Ostrega, D., Bell, G.I., Pontoglio, M., Yaniv, M., Philipson, L. et al. (1998) Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. J. Biol. Chem., 273, 24457-24464.
83. van den Ouweland, J.M., Lemkes, H.H., Ruitenbeek, W., Sandkuijl, L.A., de Vijlder, M.F., Struyvenberg, P.A., van de Kamp, J.J. and Maassen, J.A. (1992) Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet., 1, 368-371.
84. Maechler, P. and Wollheim, C.B. (2001) Mitochondrial function in normal and diabetic β-cells. Nature, 414, 807-812.
85. Wollheim, C.B. (2000) β-Cell mitochondria in the regulation of insulin secretion: A new culprit in type II diabetes. Diabetologia, 43, 265-277.
86. Weng, J., Macfarlane, W.M., Lehto, M., Gu, H.F., Shepherd, L.M., Ivarsson, S.A., Wibell, L., Smith, T. and Groop, L.C. (2001) Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia, 44, 249-258.
87. Triggs-Raine, B.L., Kirkpatrick, R.D., Kelly, S.L., Norquay, L.D., Cattini, P.A., Yamagata, K., Hanley, A.J., Zinman, B., Harris, S.B., Barrett, P.H. et al. (2002) HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc. Natl Acad. Sci. USA, 99, 4614-4619.
88. Stone, L.M., Kahn, S.E., Fujimoto, W.Y., Deeb, S.S. and Porte, D. Jr (1996) A variation at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes, 45, 422-428.
89. Kennedy, E.D., Maechler, P. and Wollheim, C.B. (1998) Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes, 47, 374-380.
90. Saleh, M.C., Wheeler, M.B. and Chan, C.B. (2002) Uncoupling protein-2: Evidence for its function as a metabolic regulator. Diabetologia, 45, 174-187.
91. Zhang, C.Y., Baffy, G., Perret, P., Krauss, S., Peroni, O., Grujic, D., Hagen, T., Vidal-Puig, A.J., Boss, O., Kim, Y.B. et al. (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β-cell dysfunction, and type 2 diabetes. Cell, 105, 745-755.
92. Chan, C.B., De Leo, D., Joseph, J.W., McQuaid, T.S., Ha, X.F., Xu, F., Tsushima, R.G., Pennefather, P.S., Salapatek, A.M. and Wheeler, M.B. (2001) Increased uncoupling protein-2 levels in β -cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes, 50, 1302-1310.
93. Krempler, F., Esterbauer, H., Weitgasser, R., Ebenbichler, C., Patsch, J.R., Miller, K., Xie, M., Linnemayr, V., Oberkofler, H. and Patsch, W. (2002) A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes, 51, 3331-3335.
94. Esterbauer, H., Schneider, C., Oberkofler, H., Ebenbichler, C., Paulweber, B., Sandhofer, F., Ladurner, G., Hell, E., Strosberg, A.D., Patsch, J.R. et al. (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat. Genet., 28, 178-183.
95. Sesti, G., Cardellini, M., Marini, M.A., Frontoni, S., D'Adamo, M., Del Guerra, S., Lauro, D., De Nicolais, P., Sbraccia, P., Del Prato, S. et al. (2003) A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes, 52, 1280-1283.
96. Poulton, J., Luan, J., Macaulay, V., Hennings, S., Mitchell, J. and Wareham, N.J. (2002) Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study. Hum. Mol. Genet., 11, 1581-1583.
97. Casteels, K., Ong, K., Phillips, D., Bendall, H. and Pembrey, M. (1999) Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet, 353, 1499-1500.
98. Hales, C.N., Barker, D.J., Clark, P.M., Cox, L.J., Fall, C., Osmond, C. and Winter, P.D. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J., 303, 1019-1022.
99. Poulton, J. (1998) Does a common mitochondrial DNA polymorphism underlie susceptibility to diabetes and the thrifty genotype? Trends Genet., 14, 387-389.
100. Miller, K.W., Dawson, J.L. and Hagelberg, E. (1996) A concordance of nucleotide substitutions in the first and second hypervariable segments of the human mtDNA control region. Int. J. Legal Med., 109, 107-113.
101. Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J. et al. (1999) Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402, 880-883.
102. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W. and Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet., 20, 284-287.
103. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C. et al. (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet., 26, 76-80.
104. Mori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T. et al. (2001) The Pro12→-A1a substitution in PPAR- is associated with resistance to development of diabetes in the general population: Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes, 50, 891-894.
105. Kim, H.I., Cha, J.Y., Kim, S.Y., Kim, J.W., Roh, K.J., Seong, J.K., Lee, N.T., Choi, K.Y., Kim, K.S. and Ahn, Y.H. (2002) Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells. Diabetes, 51, 676-685.
106. Kim, H.I., Kim, J.W., Kim, S.H., Cha, J.Y., Kim, K.S. and Ahn, Y.H. (2000) Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes, 49, 1517-1524.
107. Patane, G., Anello, M., Piro, S., Vigneri, R., Purrello, F. and Rabuazzo, A.M. (2002) Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes, 51, 2749-2756.
108. Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G. and Attardi, G. (1999) Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science, 286, 774-779.
109. Petersen, K.F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D.L., DiPietro, L., Cline, G.W. and Shulman, G.I. (2003) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science, 300, 1140-1142.
110. Golay, A., Chen, Y.D. and Reaven, G.M. (1986) Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J. Clin. Endocrinol. Metab., 62, 1081-1088.
111. Reaven, G.M., Hollenbeck, C., Jeng, C.Y., Wu, M.S. and Chen, Y.D. (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes, 37, 1020-1024.
112. Gribble, F.M., Proks, P., Corkey, B.E. and Ashcroft, F.M. (1998) Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA. J. Biol. Chem., 273, 26383-26387.
113. + channel by long chain acyl-CoA. A role in modulation of pancreatic β -cell glucose sensitivity. J. Biol. Chem., 271, 10623-10626.
114. Joseph, J.W., Koshkin, V., Zhang, C.Y., Wang, J., Lowell, B.B., Chan, C.B. and Wheeler, M.B. (2002) Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes, 51, 3211-3219.
115. Koshkin, V., Wang, X., Scherer, P.E., Chan, C.B. and Wheeler, M.B. (2003) Mitochondrial functional state in clonal pancreatic β -cells exposed to free fatty acids. J. Biol. Chem., 278, 19709-19715.
116. Lameloise, N., Muzzin, P., Prentki, M. and Assimacopoulos-Jeannet, F. (2001) Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes, 50, 803-809.
117. ATP channels in pancreatic β-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat. Med., 2, 1344-1347.
118. Thomas, P.M., Cote, G.J., Wohllk, N., Haddad, B., Mathew, P.M., Rabl, W., Aguilar-Bryan, L., Gagel, R.F. and Bryan, J. (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science, 268, 426-429.
119. Glaser, B., Thornton, P., Otonkoski, T. and Junien, C. (2000) Genetics of neonatal hyperinsulinism. Arch. Dis. Child Fetal Neonatal Edn, 82, F79-F86.
120. Huopio, H., Otonkoski, T., Vauhkonen, I., Reimann, F., Ashcroft, F.M. and Laakso, M. (2003) A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet, 361, 301-307.
121. + channels in cell survival and differentiation in the endocrine pancreas. Diabetes, 50, S48-S51.
122. Glaser, B., Ryan, F., Donath, M., Landau, H., Stanley, C.A., Baker, L., Barton, D.E. and Thornton, P.S. (1999) Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes, 48, 1652-1657.
123. Kassem, S.A., Ariel, I., Thornton, P.S., Scheimberg, I. and Glaser, B. (2000) β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes, 49, 1325-1333.
124. Thornton, P.S., MacMullen, C., Ganguly, A., Ruchelli, E., Steinkrauss, L., Crane, A., Aguilar-Bryan, L. and Stanley, C.A. (2003) Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes, 52, 2403-2410.
125. Giugliano, M., Bove, M. and Grattarola, M. (2000) Insulin release at the molecular level: Metabolic-electrophysiological modeling of the pancreatic β-cells. IEEE Trans. Biomed. Eng., 47, 611-623.
126. Smith, P.A., Sakura, H., Coles, B., Gummerson, N., Proks, P. and Ashcroft, F.M. (1997) Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic β-cells. J. Physiol., 499, 625-635.
127. + current by muscarinic receptors in mouse pancreatic β-cells. J. Biol. Chem., 277, 38373-38380.
128. Fernandez, J. and Valdeolmillos, M. (1999) Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic β-cells recorded in vivo. Diabetes, 48, 754-757.